Dupilumab-associated mycosis fungoides: a cross-sectional study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Dermatology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00403-023-02652-z.pdf
Reference31 articles.
1. Silverberg JI, Kantor R (2017) The role of interleukins 4 and/or 13 in the pathophysiology and treatment of atopic dermatitis. Dermatol Clin 35(3):327–334
2. Amorim GM, Niemeyer-Corbellini JP, Quintella DC, Cuzzi T, Ramos-E-Silva M (2018) Clinical and epidemiological profile of patients with early stage mycosis fungoides. An Bras Dermatol 93(4):546–552
3. Saulite I, Hoetzenecker W, Weidinger S, Cozzio A, Guenova E, Wehkamp U (2016) Sézary syndrome and atopic dermatitis: comparison of immunological aspects and targets. Biomed Res Int 2016:9717530
4. Ayasse M, Nelson K, Glass F, Silverberg JI (2021) Mycosis fungoides unmasked by dupilumab treatment in a patient with a history of atopic dermatitis. Dermatitis 32(1S):e88–e89
5. Espinosa ML, Nguyen MT, Aguirre AS et al (2020) Progression of cutaneous T-cell lymphoma after dupilumab: case review of 7 patients. J Am Acad Dermatol 83(1):197–199
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term Remission of Severe and Refractory Chronic Actinic Dermatosis with Dupilumab: A Case Report with Review of the Literature;Acta Dermato-Venereologica;2024-08-23
2. ATOPİK DERMATİT TEDAVİSİNDE BİYOLOJİK İLAÇLAR: LİTERATÜR TARAMASI;Journal of Anatolian Medical Research;2024-06-11
3. Cutaneous T‐cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes;Journal of the European Academy of Dermatology and Venereology;2024-05-31
4. Role of IL-4 and IL-13 in Cutaneous T Cell Lymphoma;Life;2024-02-09
5. Increased Risk of Cutaneous T‐Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis;Dermatologic Therapy;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3